welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
New Research Verifies TASINs as Viable Target for Colon Cancer Therapies
A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated. The mutated cells that are killed using TASIN-1 are found in more than 80 percent of colon tumors.
The findings could eventually help with both prevention and intervention efforts for colon cancer, which according to the National Cancer Institute is the third most common type of cancer in men and women and the second leading cause of cancer-related mortality in the United States.
expertly curated content related to this topic
-
A Germline Homozygous Loss-of-Function Mutation in the Base Excision Repair Gene NTHL1 Causes Adenomatous Polyposis ...Abstract Introduction: Patients diagn...
-
Pathways of Colorectal CarcinogenesisThis review of the molecular and cellula...
-
ERβ Expression in Normal, Adenomatous and Carcinomatous Tissues of Patients with Familial Adenomatous PolyposisOBJECTIVES : The APC gene mutation trigg...
-
Biomarkers in Familial Adenomatous Polyposis: Role and SignificanceA biomarker, according to a generally ac...
-
MutYH-Associated Colon Disease: Adenomatous Polyposis is Only One of the Possible Phenotypes; A Family Report and Li...AIMS AND BACKGROUND: The MutY human hom...
-
Risk of Colorectal Cancer For Carriers of Mutations in MutYH, With and Without a Family History of CancerWe studied 2332 individuals with monoall...
-
Functional Analysis of MUTYH Mutated Proteins Associated with Familial Adenomatous PolyposisThe MUTYH DNA glycosylase specifically r...